TACE治疗原发性肝癌患者血清肿瘤标志物水平变化

doi:10.3969/j.issn.1672-5069.2018.01.033

Abstract

Yang Haiqing, Sun Weina. Changes of serum tumor markers in patients with hepatocellular carcinoma before and after TACE treatment[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(1): 123-124.

[1] Kallini JR,Gabr A,Abouchaleh N,et al. New developments in interventional oncology:Liver metastases from colorectal cancer. Cancer,2016,22:373-380.
[2] 敖平.DC-CIK/CIK 联合射频消融术+肝动脉化疗栓塞术治疗肝细胞癌的 Meta 分析. 广东医学,2016,37（22）:222-228.
[3] Mastoraki A,Benetou C,Mastoraki S,et al. The role of surgery in the therapeutic approach of gastric cancer liver metastases. Indian J Gastroenterol,2016,35:331-336.
[4] 王小林,王虎,何发清,等. 肝细胞癌经导管肝动脉化疗栓塞术治疗后CT检查与评价. 山东大学学报（医学版）,2014,52（22）:74-75.
[5] Ippolito D,Trattenero C,Talei FC,et al. Dynamic contrast-enhanced magnetic resonance imaging with gadolinium ethoxybenzyl eiethylenetriamine pentaacetic acid for quantitative assessment of vascular effects on hepatocellular-carcinoma lesions treated by transarterial chemoembolization or radiofrequency ablation. Comput Assist Tomogr,2016,40:692-700.
[6] 李勇,毕涛,张炳远,等. 中国肝细胞癌患者TACE术后死亡原因分析. 现代生物医学进展,2014,14（26）:5152-5157.
[7] Takada K,Ito T,Kumada T,et al. Extra-hepatic feeding arteries of hepatocellular carcinoma:An investigation based on intra-
arterial CT aortography images using an angio-MDCT system. Eur Radiol,2016,85:1400-6.
[8] 胥栋,袁伟东. 肝动脉插管化疗栓塞术治疗原发性肝癌临床疗效分析. 实用肝脏病杂志,2015,18（2）:195-196.
[9] Sheta E,El-Kalla F,El-Gharib M,et al. Comparison of single-session transarterial chemoembolization combined with microwave ablation or radiofrequency ablation in the treatment of hepatocellular carcinoma:a randomized-controlled study. Eur J Gastroenterol Hepatol,2016,28:1198-203.
[10] Miyayama S,Matsui O. Superselective conventional transarterial chemoembolization for hepatocellular carcinoma:Rationale,technique,and outcome.Vasc Interv Radiol,2016,27:1269-1278.
[11] 纪文斌,肖年军,罗英,等.甲胎蛋白与异常凝血酶原在鉴别诊断肝细胞癌中的价值.中华肝胆外科杂志,2016,22（3）:145-149.
[12] Johnson GE,Monsky WL,Valji K,et al. Yttrium-90 radioembolization as a salvage treatment following chemoembolization for hepatocellular carcinoma. J Vasc Interv Radiol,2016,27:1123-1129.
[13] 陈安,杨振宇,杜锡林,等. 经肝动脉栓塞化疗联合门静脉化疗对预防肝细胞癌切除术后复发的研究.西部医学,2016,28（7）:925-927,931.
[14] Walsworth MK,Yap FY,McWilliams JP. Aberrant systemic arterial supply to normal lung arising from the proper hepatic artery discovered during transarterial chemoembolization. Radiol Case Rep,2015,9:24-31.
[15] 李仕来,黎乐群.经导管肝动脉化疗栓塞术在肝细胞癌中的治疗进展.医学综述,2015,9（17）:3126-3129.
[16] Kim GM,Kim MD,Kim dY,et al. Transarterial chemoembolization using sorafenib in a rabbit VX2 liver tumor model:Pharmacokinetics and antitumor effect. Vasc Interv Radiol,2016,27:1086-1092.

Changes of serum tumor markers in patients with hepatocellular carcinoma before and after TACE treatment

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Cao Ce, Yu Yixing, Wang Beibei, et al.. Clinical diagnostic efficacy of enhanced magnetic resonance imaging combined with serum AFP and PIVKA-Ⅱ in the diagnosis of patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 896-899.
[2]	Xing Hao, Han Jun, Yang Tian.. Diagnostic value of serum protein induced by vitamin K absence or antagonist II for hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 934-937.
[3]	Zhu Jun, Ding Ying, Wang Shiqing, et al. Peripheral blood Th22 cells and plasma interleukin-22 level changes in patients with hepatocellular carcinoma after hepatectomy and administration of ulinastatin [J]. Journal of Practical Hepatology, 2019, 22(5): 720-723.
[4]	Wang Gang, Zhao Hongbo, Zhu Yaling, et al. Cancerous XPO5 gene level in patients with hepatocellular carcinoma and its clinical significance [J]. Journal of Practical Hepatology, 2019, 22(5): 724-727.
[5]	Qiao Zhizhong. Value of contrast-enhanced ultrasonography in differential diagnosis of patients with focal nodular hyperplasia and hepatocellular carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 421-424.
[6]	Zhu Guangxi，Wen Liangzhi，Chen Dongfeng. Pathogenesis of non-alcoholic fatty liver disease-related hepatocellular carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 453-456.
[7]	Wang Huming, Fan Dongsheng, Xu Jie, Liu Xianfegn, Zhou Ning, Li Min, Bao Nana. Cancerous miRNA-30c levels affecting the survival of patients with hepatocellular carcinoma after hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 248-251.
[8]	Xing Diankui, Cheng Jing. Clinical value of ¹⁸F-FDG PET/CT scan in patients with hepatocellular carcinoma and hepatic microvascular invasion [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 252-254.
[9]	Wang Xiuqing, Ma Yanjun, Zhan Jinli. Efficacy of transcatheter arterial chemoembolization and ultrasound-guided microwave ablation in the treatment of patients with hepatocellular carcinoma at special sites [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 260-263.
[10]	Zhang Xiaozhou, Shuai Ling, Wang Qingda, Yang Nan. Changes of serum miR-335 levels in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 268-271.
[11]	Wang Zhaoxia, Guan Ke, Fu Sanxian, Wang Huijie. Early administration of enteral nutrition in patients with hepatocellular carcinoma undergoing hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 272-275.
[12]	Zhao Xitai, Nie Qinghe. Serum microRNA in diagnosis of patients with hepatocellular carcinoma and methodological progress [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 297-300.
[13]	Fan Jiangao.. Highlights of Journal of Practical Hepatology in 2018 [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 1-3.
[14]	Chen Yongqi, Chen Qian, Yuan Chunyan, et al.. Cancerous and noncancerous expression of Ep-CAM and C-Kit in patients with hepatocellular carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 109-112.
[15]	Ouyang Shi, Chen Xiaoping, Cheng Tao, et al.. Correlation of HLA-A,-B,-C,-DRB1,-DQB1 alleles to hepatocellular carcinoma development in patients with hepatitis B viral infection [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 940-946.